Active ingredients: suvorexant
What it is used for
BELSOMRA is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance. Following initiation of treatment, continuation should be re-evaluated after 3 months (see CLINICAL TRIALS and ADVERSE EVENTS for clinical trial durations).
How to take it
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Store in Original Container
- Lifetime is 36 Months.
Always read the label. If symptoms persist see your healthcare professional.
White, oval, biconvex, film coated tablet, marked with Merck logo and 325 on one side and plain on the other side
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Sleeping tablets work on pathways in the brain which are important in regulating whether someone is awake or asleep. Most sleeping tablets make the ‘sleep pathways’ more active. One of the newer medications works by making the ‘wake pathways’ less active.
Read more on Sleep Health Foundation website